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Abstract
Purpose: The purposes of the present study were: (1) to determine whether the physical working capacity at the fatigue threshold (PWCFT) model
that has been used for estimating the onset of neuromuscular fatigue in the vastus lateralis (VL) during incremental treadmill running could also
be applied to the vastus medialis (VM), biceps femoris (BF), and semitendinosus (ST) muscles; and (2) if applicable, to compare the running
velocities associated with the PWCFT among these muscles.
Methods: Eleven subjects (age 21.7 § 1.8 years) performed an incremental treadmill test to exhaustion with electromyographic signals recorded
from the VL, VM, BF, and ST.
Results: The results indicated there were no significant (p > 0.05) mean differences in the running velocities associated with the PWCFT for the
VL (14.4 § 2.0 km/h), VM (14.3 § 1.9 km/h), BF (13.8 § 1.8 km/h), and ST (14.7 § 2.3 km/h). In addition, there were significant inter-correla-
tions (r = 0.680.88) among running velocities associated with the PWCFT of each muscle. Individual results also indicated that 9 of the 11 sub-
jects exhibited identical PWCFT values for at least 3 of the 4 muscles, but there were no uniform patterns for any intra-individual differences.
Conclusion: The findings of the present study suggested that the PWCFT test is a viable method to identify neuromuscular fatigue in the quadri-
ceps and hamstrings during incremental treadmill exercise and results in consistent PWCFT values among these muscles.
Keywords: EMG amplitude; Muscle activation; PWCFT
1. Introduction
The physical working capacity at the fatigue threshold
(PWCFT) test of deVries et al.
1 estimates the maximal power
output that can be sustained for an extended period of time
without evidence of neuromuscular fatigue during cycle ergo-
metry. Specifically, the PWCFT test is based on within-stage
increases in electromyographic (EMG) amplitude that reflect
fatigue-induced increases in muscle activation (i.e., motor unit
recruitment and firing rates) required to maintain the desired
power output. It has been demonstrated that the PWCFT pro-
vides an accurate measurement of the highest non-fatiguing
workload2 and results in consistent values among superficial
muscles of the quadriceps (i.e., vastus lateralis (VL), rectus
femoris (RF), and vastus medialis (VM).3 Previous studies
have used the PWCFT test to examine physiological factors
associated with neuromuscular fatigue,46 to assess physical
fitness7 and factors related to the degeneration of neuromuscu-
lar function8,9 in the elderly, to prescribe exercise training
intensities,10 as well as to determine the effectiveness of exer-
cise training programs11 and various nutritional supplements
as ergogenic aids.1216 Collectively, these findings illustrate
that the PWCFT serves as a valid and reliable tool for estimat-
ing the onset of neuromuscular fatigue during cycle ergometry
with athletic performance and clinical applications.
Recently, Camic et al.17 applied the PWCFT model used for
cycle ergometry to incremental treadmill exercise to derive a
new neuromuscular fatigue threshold test for running.
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Utilizing the method of deVries et al.1 and recording the EMG
signal from the VL, Camic et al.17 reported that the PWCFT
model was able to identify fatiguing from non-fatiguing run-
ning velocities by examining the slope coefficients for the
EMG amplitude vs. time relationships during each 2-min stage
of an incremental treadmill test to exhaustion. Theoretically,
the PWCFT treadmill test estimates the fastest running velocity
that can be sustained without progressive increases in muscle
activation to compensate for the development of fatigue. It
was also reported that the running velocity associated with the
PWCFT from the VL was significantly correlated (r = 0.70)
and occurred at the same running velocity (14.0 § 2.3 km/h,
mean § SD) as the respiratory compensation point (RCP)
(14.0 § 1.8 km/h).17 These findings suggested that the PWCFT
determined from the VL during incremental treadmill exercise,
like the RCP, (1) can be used to identify the boundary between
the heavy and severe domains of exercise intensity, and (2)
represents the maximal exercise intensity that can be achieved
with oxygen uptake (VO2) and lactate still maintaining a
steady state.18 It has recently been demonstrated, however,
that the patterns (linear, quadratic, cubic) of responses for
muscle activation (i.e., EMG amplitude) across exercise inten-
sity (i.e., VO2) are unique among muscles of the thigh and
may be due to variations in muscle architecture, fiber type, or
biomechanical differences.19 A number of other studies2023
have also reported differences in muscle-activation patterns
between the quadriceps and hamstring groups with increases
in running velocity or the development of fatigue. For exam-
ple, Kyr€ol€ainen et al.21 showed that biarticular muscles (e.g.,
biceps femoris) exhibited changes in muscle activity across
running phases with increases in velocities from 4.0 m/s to
8.5 m/s that were distinct from the activation patterns of mono-
articular muscles (e.g., VL). Thus, it is currently unknown
whether the PWCFT model is applicable to other muscles of
the quadriceps as well as the hamstrings while running due to
these variations in activation. Based on the anatomical and
biomechanical differences that exist among these muscles, an
assessment of their fatigue-induced activation strategies is
warranted. Therefore, the purposes of the present study were:
(1) to determine whether the PWCFT model that has been used
for estimating the onset of neuromuscular fatigue in the VL
during incremental treadmill running could also be applied to
the VM, biceps femoris (BF), and semitendinosus (ST)
muscles; and (2) if applicable, to compare the running veloci-
ties associated with the PWCFT among these muscles.
2. Methods
2.1. Subjects
Nine college-aged males (age = 22.0 § 1.7 years, body
mass = 75.5 § 9.0 kg, height = 178.2 § 5.8 cm) and 2 females
(20.5§ 2.1 years, 58.7 § 3.1 kg, 165.8§ 9.8 cm) volunteered to
participate in this investigation. These subjects were selected
based on their diverse running backgrounds, which included reg-
ular participation in recreational races (i.e., 5 km, 10 km) (n = 3),
marathons (n = 4), ultramarathons (n =1), triathlons (n = 1),
collegiate track (n = 1), and collegiate soccer (n = 1). Each subject
visited the laboratory on 2 occasions (separated by at least 48 h)
and was instructed to: (1) maintain normal dietary habits and
sleep patterns during the course of the study and (2) avoid exer-
cise for 48 h, caffeine and alcohol for 24 h, and food intake for 3
h prior to each visit. The study was approved by the University of
Wisconsin-La Crosse Institutional Review Board for Human
Subjects, and all subjects completed a health history question-
naire and signed a written informed consent prior to testing.
2.2. Incremental Treadmill Tests
The first laboratory visit was structured as an orientation
session to familiarize the subjects with the testing procedures
(i.e., measurement of gas exchange and EMG while running
on a treadmill). During the second laboratory visit, each sub-
ject performed an incremental test to exhaustion for the deter-
mination of PWCFT, RCP, and peak oxygen uptake (VO2peak).
The incremental treadmill test involved a standard warm-up of
walking at 4.86.4 km/h for 4 min. Immediately following the
warm-up, the test began at 9.7 km/h and increased 1.6 km/h
every 2 min until volitional fatigue. This increment of
1.6 km/h was consistent with the original protocol17 and was
selected for the practical purpose of estimating the PWCFT
across a wide range of running velocities in the diverse sample.
The grade remained constant at 1.0% during the test and was
selected to represent the energy cost that is typically experi-
enced by running outdoors.24
2.3. EMG Measurements and Signal Processing
During the second laboratory visit, bipolar (10 mm center-
to-center) wireless surface electrode sensors (Tringo Lab Wire-
less EMG System; Delsys, Natick, MA, USA) were placed on
the right thigh over the VL, VM, BF, and ST muscles accord-
ing to the recommendations of the SENIAM Project.25 Because
of the lack of reliability of the EMG signal for the RF,26,27 this
muscle was not examined. Prior to electrode sensor placement,
the skin at each electrode site was dry-shaved, lightly abraded
with gauze, and cleaned with alcohol. The EMG signals were
amplified (gain:£ 1000) (Tringo Lab Wireless EMG System,
bandwidth = 20450 Hz), sampled at 2000 Hz, recorded
continuously throughout the incremental test, and stored in a
personal computer (Latitude E6540; Dell Inc., Round Rock,
TX, USA) for subsequent analyses. All signal processing was
performed using custom programs, which were written with
MATLAB programming software (Version 8.2; Mathworks,
Natick, MA, USA). The EMG signals were digitally bandpass
filtered (fourth-order Butterworth) at 20450 Hz.
2.4. Determination of PWCFT
The PWCFT values were determined using the model of
deVries et al.1 During each 2-min stage of the incremental
treadmill test, six 10-s EMG samples were selected from the
signal (1020 s, 3040 s, 5060 s, 7080 s, 90100 s, and
110120 s). The EMG amplitude (microvolts root mean
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square, mVrms) values were calculated for each of the 10-s
epochs (MATLAB) and separately plotted across time for
each stage (i.e., running velocity) of the test (Fig. 1). The
PWCFT for each muscle was defined as the average of
the highest running velocity that resulted in a nonsignificant
(p > 0.05, single-tailed t test) slope coefficient for the EMG
amplitude vs. time relationship and the lowest running velocity
that resulted in a significant (p < 0.05) positive slope
coefficient (Fig. 1).
2.5. Measurements of Gas Exchange
All subjects wore a nose clip and breathed through a 2-way
valve (2700, Hans Rudolph, Kansas City, MO, USA) during
the incremental tests. Expired gas samples were collected
and analyzed using a calibrated metabolic cart AEI Moxus
(AEI Technologies, Pittsburgh, PA, USA) with O2, CO2, and
ventilatory parameters expressed as 30-s averages. Each subject
was also fitted with a Polar Heart Watch system (Polar Electro,
Lake Success, NY, USA) to monitor heart rate throughout the
test. VO2peak was defined as the highest VO2value in the last
30 s of the exercise test that met the criteria of Day et al.28 The
testretest reliability for VO2peak testing from our laboratory
indicated that the intraclass correlation coefficient was R = 0.95,
and the standard error of measurement29 (SEm) = 97 mL/min,
with no significant (p > 0.05) mean difference between test
and retest values. The RCP was determined by noninvasive
gas-exchange measurements using the method of Beaver et
al.30 For each subject, running velocities from the incremental
treadmill test attained during the second laboratory visit were
plotted against VO2values, and the regression equation derived
was used to determine the running velocity that corresponded
to their RCP. The testretest reliability for RCP testing from
our laboratory indicated that the intraclass correlation coeffi-
cient was R = 0.93, and SEm = 103 mL/min, with no significant
mean difference between test and retest values.
2.6. Statistical Analyses
Mean § SD values were calculated for the PWCFT from the
VL, VM, BF, and ST as well as RCP and VO2peak. For deter-
mination of PWCFT values, the relationships for EMG ampli-
tude vs. time for each individual muscle and running velocity
were examined using linear regression (IMB SPSS Statistics,
Version 24; IMB Corp., Armonk, NY, USA). A 1-way
repeated-measures ANOVA was also used to determine
whether there were significant mean differences in running
velocities among the PWCFT from each muscle and the RCP.
Follow-up post hoc analyses included paired t tests with Bon-
ferroni correction. A 0-order correlation matrix was used to
determine the relationships among the PWCFT from each
muscle and the RCP. An a < 0.05 was considered statistically
significant for the 1-way repeated-measures ANOVA and all
0-order correlations.
3. Results
The results of the 1-way repeated-measures ANOVA and
post hoc analyses indicated there were no significant (p > 0.05)
differences among the running velocities associated with the
VL PWCFT, VM PWCFT, BF PWCFT, ST PWCFT, and RCP
(Table 1). In addition, the individual running velocities associ-
ated with the PWCFT were identical for all 4 muscles in 2 sub-
jects, 3 of the 4 muscles in 7 subjects, and 2 of the 4 muscles in
2 subjects (Table 2). There were no consistent intra-subject pat-
terns for the PWCFT values that distinguished the VL, VM, BF,
and ST muscles (Table 2). Furthermore, there were significant
(p < 0.05) 0-order correlations (r = 0.600.88) among the run-
ning velocities associated with the VL PWCFT, VM PWCFT, BF
PWCFT, ST PWCFT, and RCP, except for the VM vs. RCP
(r = 0.52) (Table 3).
Fig. 1. Illustration of the method used to determine the physical working
capacity at the fatigue threshold (PWCFT) during treadmill running. The
PWCFT in this example (15.3 km/h) was calculated by averaging the highest
running velocity (14.5 km/h) that resulted in a non-significant (p > 0.05) slope
coefficient for the EMG amplitude vs. time relationship and the lowest running
velocity (16.1 km/h) that resulted in a significant (p < 0.05) slope coefficient.
* Slope significantly (p < 0.05) greater than 0.
Table 1
Physical characteristics, running velocities, and metabolic parameters of the
subjects (n = 11).
Variable Mean § SD Range
Age (year) 21.7 § 1.8 19.025.0
Body mass (kg) 73.9 § 9.8 56.586.9
Height (cm) 176.8 § 7.7 158.8185.4
Running volume (km/week) 45.2 § 39.9 6.4160.9
PWCFT (km/h)
VL 14.4 § 2.0 10.516.9
VM 14.3 § 1.9 10.516.9
BF 13.8 § 1.8 10.516.9
ST 14.7 § 2.3 10.518.5
RCP (km/h) 14.5 § 1.7 12.417.5
RCP (L/min) 4.08 § 0.77 2.684.98
VO2peak (L/min) 4.78 § 0.84 3.115.53
VO2peak (mL/kg/min) 64.4 § 9.4 51.178.1
Notes: No significant differences (p > 0.05) were found among the running
velocities associated with the PWCFT values for the vastus lateralis, vastus
medialis, biceps femoris, or semitendinosus muscles as well as the RCP.
Abbreviations: BF = biceps femoris; PWCFT = physical working capacity at
the fatigue threshold; RCP = respiratory compensation point; ST = semitendi-
nosus; VL = vastus lateralis; VM = vastus medialis; VO2peak = peak oxygen
uptake.
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4. Discussion
One of the main findings of the present study was that the
PWCFT model that has been used to estimate neuromuscular
fatigue in the VL17 during incremental treadmill running was
also applicable to other muscles of the quadriceps femoris
(VM) and hamstring (BF, ST) groups. That is, the PWCFT
method of deVries et al.1 was able to identify fatiguing from
non-fatiguing running velocities during the incremental tread-
mill test by statistically examining the slope coefficient of the
EMG amplitude vs. running velocity relationship of each stage
for all muscles. Specifically, the EMG amplitude values at the
velocities associated with fatigue increased across time for the
VL (r = 0.740.99), VM (r = 0.780.99), BF (r = 0.760.98),
and ST (r = 0.770.99) for all subjects, whereas the non-
fatiguing running velocities resulted in non-significant rela-
tionships. These findings illustrated that the PWCFT test is a
viable tool for estimating the running velocities associated
with neuromuscular fatigue in individual muscles of the thigh.
Previous studies20,23,31 using other methods have also identi-
fied neuromuscular fatigue in various lower-limb muscles
based on increases in EMG amplitude during running. For
example, Hanon et al.20,23 examined the difference in EMG
amplitude values associated with 510 running bursts of acti-
vation at 0:45 (min:s) and 3:40 (min:s) of each 4-min stage for
the VL, BF, gluteus maximus, RF, tibialis anterior, and
gastrocnemius muscles during discontinuous, incremental
treadmill running to exhaustion. In these studies,20,23 running
velocities were defined as “fatiguing” if they exhibited signifi-
cant increases in EMG amplitude at the end compared to the
beginning of a stage. One of the major advantages of the
PWCFT model
1,17 used in the present study, however, is the
evaluation of change in EMG amplitude across the entire
stage, compared to only 510 running bursts of activation at 2
different time points. Thus, the use of the PWCFT model
1,17
may provide greater insight into the evolution of fatigue during
incremental treadmill running and may be less susceptible to
outliers that exist among EMG activation bursts.
The findings of the present investigation also indicated that
there were no significant mean differences in running veloci-
ties associated with the VL PWCFT (14.4 § 2.0 km/h), VM
PWCFT (14.3 § 1.9 km/h), BF PWCFT (13.8 § 1.8 km/h), and
ST PWCFT (14.7 § 2.3 km/h) (Table 1). In addition, there
were significant inter-correlations for the PWCFT values that
existed among all muscles (r = 0.680.88) (Table 3). There-
fore, the identification of neuromuscular fatigue for the VL,
VM, BF, and ST was associated with the same running veloc-
ity and was consistent among all muscles. These findings were
similar with those of Housh et al.,3 which indicated that the
PWCFT occurred at the same power output for the superficial
muscles of the quadriceps during incremental cycle ergometry.
Using the PWCFT model and 30-W incremental stages, the
authors3 reported: (1) no significant differences in the power
output associated with neuromuscular fatigue for the VL (226
§ 58 W), VM (223 § 58 W), and RF (203 § 54 W), and (2)
significant inter-correlations (r = 0.780.92) among the
muscles. In conjunction, the findings of the present study and
those of Housh et al.3 suggested that the PWCFT serves as a
reliable tool to identify neuromuscular fatigue during incre-
mental treadmill running and cycle ergometry. It is important
to note, however, that the running velocities associated with
the PWCFT in the current investigation were identical for: (1)
all 4 muscles in 2 subjects, (2) 3 muscles for 7 subjects, and
(3) 2 muscles for 2 subjects (Table 2). As proposed by Housh
et al.,3 it is possible that these intra-subject differences in the
PWCFT among muscles may be due to variations in fiber-type
distribution, training status or protocols, and biomechanical
differences. Thus, the current findings suggested that an exam-
ination into intra-subject variability in the PWCFT can be used
to identify muscle imbalances among the quadriceps and ham-
string groups during running as well as to determine individual
training strategies for athletes. For example, the potential uses
for PWCFT identification in various muscles of interest
include: (1) to determine the effectiveness of training pro-
grams through pre- and post-assessments, (2) to prescribe exer-
cise training intensities (i.e., running velocities) based on
%PWCFT, (3) to assess the impact of running-form adjust-
ments on fatigue-related aspects of muscle activation, and (4)
to assess the rehabilitative progress in recovering from injury.
It is also possible that the PWCFT protocol could be modified
to identify muscle fatigue across differing velocities and
grades, depending on performance requirements. In particular,
deVries et al.1 suggested that the PWCFT treadmill test could
Table 2
Individual PWCFT values (km/h) for each muscle and subject.
Subject code VL VM BF ST
1 16.9 16.9 16.9 16.9
2 15.3 15.3 13.7 15.3
3 12.1 10.5 10.5 10.5
4 15.3 15.3 13.7 15.3
5 15.3 12.1 13.7 13.7
6 15.3 15.3 13.7 15.3
7 10.5 13.7 13.7 13.7
8 13.7 13.7 13.7 13.7
9 13.7 13.7 12.1 12.1
10 16.9 16.9 16.9 18.5
11 13.7 13.7 13.7 16.9
Abbreviations: BF = biceps femoris; PWCFT = physical working capacity at
the fatigue threshold; ST = semitendinosus; VL = vastus lateralis; VM = vastus
medialis.
Table 3
Correlations among running velocities associated with the PWCFT of each
muscle and respiratory compensation point.
RCP VL VM BF ST
RCP 
VL 0.60* 
VM 0.52 0.70* 
BF 0.80* 0.69* 0.85* 
ST 0.85* 0.68* 0.84* 0.88* 
* p < 0.05.
Abbreviations: BF = biceps femoris; PWCFT = physical working capacity at
the fatigue threshold; RCP = respiratory compensation point; ST = semitendi-
nosus; VL = vastus lateralis; VM = vastus medialis.
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be customized for the elderly by using slower velocities to
assess fatigue-related aspects of neuromuscular function dur-
ing walking. Therefore, the PWCFT treadmill test has practical
applications that can be potentially useful in both athletic and
special populations.
The PWCFT values for each muscle (VL = 14.4 § 2.0 km/h,
VM = 14.3 § 1.9 km/h, BF = 13.8 § 1.8 km/h, and ST = 14.7
§ 2.3 km/h) also occurred at the same running velocity as the
RCP (14.5 § 1.7 km/h) (Table 1). In addition, there were sig-
nificant inter-correlations among the PWCFT values for each
muscle vs. the RCP (r = 0.600.88), except the VM (r = 0.52)
(Table 3). As described previously,17 the relationships among
neuromuscular (PWCFT) and ventilatory-based thresholds
(ventilatory threshold and RCP) provide information related to
the practical applications and validity of the PWCFT treadmill
test. That is, the running velocity associated with neuromuscu-
lar fatigue in muscles of the thigh, like the RCP, demarcates
the border between the heavy and severe domains of exercise
intensity and, thus, represents the maximal running velocity
that can be maintained for an extended period of time with
VO2 and lactate still reaching a steady state.
18 In particular, it
has been established that continuous exercise above the heavy-
intensity domain results in VO2 and lactate values that do not
stabilize, and VO2 reaches its maximum.
18 These findings
offer physiological validation that the PWCFT is an accurate
estimate of the highest non-fatiguing running velocity. Practi-
cal validation of the PWCFT model during treadmill exercise
through constant runs to exhaustion at, below, and above the
estimated PWCFT, however, has not been examined.
5. Conclusions
In summary, the findings of the present investigation
illustrated that the PWCFT that has previously been used to
identify the onset of neuromuscular fatigue in the VL is also
applicable to other muscles of the thigh (i.e., VM, BF, and
ST) during incremental treadmill running. The non-signifi-
cant mean differences and significant correlations among
the running velocities of the VL PWCFT, VM PWCFT, BF
PWCFT, and ST PWCFT suggested that this neuromuscular
fatigue threshold results in consistent estimates across
muscles of the quadriceps femoris and hamstring groups
and may be used to identify muscle imbalances as well as to
determine individual training strategies for athletes. In addi-
tion, the development of fatigue in these muscles as indi-
cated by the PWCFT coincided with the running velocity
associated with the RCP. These findings provide physiologi-
cal validation for the PWCFT model during incremental
treadmill running.
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